Hanfang Jijia Su Pian (汉防己甲素片)汉防己甲素片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

汉防己甲素是一种在国家药监局注册认定的药品。标注生产企业为浙江金华康恩贝生物制药有限公司。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:浙江金华康恩贝生物制药有限公司Chinese legal name: 浙江金华康恩贝生物制药有限公司、浙江金华康恩贝生物制药有限公司Chinese legal name: 浙江金华康恩贝生物制药有限公司、浙江金华康恩贝生物制药有限公司Chinese legal name: 浙江金华康恩贝生物制药有限公司。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 汉防己甲素片) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 浙江金华康恩贝生物制药有限公司.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 浙江金华康恩贝生物制药有限公司Chinese legal name: 浙江金华康恩贝生物制药有限公司, 浙江金华康恩贝生物制药有限公司Chinese legal name: 浙江金华康恩贝生物制药有限公司, 浙江金华康恩贝生物制药有限公司Chinese legal name: 浙江金华康恩贝生物制药有限公司.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 汉防己甲素片Recorded Chinese name: 汉防己甲素片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 20mgx12片/盒Recorded Chinese specification: 20mgx12片/盒

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 浙江金华康恩贝生物制药有限公司Chinese legal name: 浙江金华康恩贝生物制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H33022075

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H33022075

Manufacturer

Chinese legal name: 浙江金华康恩贝生物制药有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Keep sealed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H33022075

生产企业

浙江金华康恩贝生物制药有限公司(国产)

适应症

用于风湿痛、关节痛、神经痛。与小剂量放射合并用于肺癌;亦用于单纯硅肺I、II、III期及各期煤硅肺。

用法用量

口服。 1.抗风湿及镇痛:每次20mg~40mg,一日3次。 2.抗肺癌:每次40mg~60mg,一日3次。 3.抗硅肺:每次60mg~100mg,一日3次,服用6天,停药1天,疗程3个月。

不良反应

部分患者服药后会有轻度嗜睡、乏力、恶心、上腹部不适,长期口服可能会引面部色素沉着,停药后可消退。

禁忌

1.肝、肾等脏器发生器质性病变患者禁用。
2.孕妇禁用。
3.对本品过敏者禁用。

注意事项

服药期间每3个月复查肝功能、心电图等。

贮藏

密封。

规格

20mgx12片/盒

证据Evidence

  • 批准文号: 国药准字H33022075
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.